New patent paves way for breast cancer prevention

(George Mason University) GMU researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages. Chloroquine, a drug commonly given to prevent or treat malaria, targets "ductal carcinoma in situ," or DCIS, the most common type of pre-invasive breast cancer. DCIS is the main precursor to invasive, metastatic, and lethal, breast cancer.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news